about
Interventional tools to improve medication adherence: review of literatureGene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinomaGenomic scale analysis of racial impact on response to IFN-alphaImpact of sample preparation in peptide/protein profiling in human serum by MALDI-TOF mass spectrometry.Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation.Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians.HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associationsScaling up health knowledge at European level requires sharing integrated data: an approach for collection of database specification.Molecular immune signatures of HIV-1 vaccines in human PBMCs"Sequencing-grade" screening for BRCA1 variants by oligo-arrays.Toward appropriate criteria in medication adherence assessment in older persons: Position Paper.Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.Adherence to Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Prescriptions Affects Overall Medication Adherence in Older Persons: Evidence From the Italian Nationwide OsMed Health-DB Database.Strategies to Improve Medication Adherence in Older Persons: Consensus Statement from the Senior Italia Federanziani Advisory Board.Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis.Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency.Prescription drug use among older adults in Italy: a country-wide perspective.Molecular and in silico analysis of BRCA1 and BRCA2 variants.BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, ItalySpontaneous and treatment-induced cancer rejection in humansIntegrated care for the management of ageing-related non-communicable diseases: current gaps and future directionsInformation and communication technology for increasing healthy ageing in people with non-communicable diseases: identifying challenges and further areas for developmentThe potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing
P50
Q26781959-53598CAB-916F-4DE0-84B1-0A51C41F89D6Q27490242-020F89F7-F0E4-48ED-8DF2-6E7DC396674AQ27490906-6A730B0E-A107-4246-93B1-B4957F94419DQ33307029-DC7D925C-9BA7-4D44-8611-7755013275F7Q33326902-B76B2DEE-85AF-4121-A44C-576E9A79D3B3Q33479314-6FC5885B-E166-4D2F-8B88-D4721FEDA61AQ34387506-8174C150-9F85-44A3-BB11-CC6B684E49DDQ35834296-0194F442-EC99-4C65-8585-6A6658218DA9Q36013021-360C5CBC-497A-481C-B4DC-A807F0B67F44Q36064517-D5FD4401-0D01-4091-B09D-43EEF8397B34Q36162887-77F00310-D309-411D-8D7C-96E45B8777B9Q36975142-5DB5C7B6-EB5D-42C2-9C7C-C537EA73620BQ38657115-8531B4DE-129D-439E-9AD6-D2C29CB8D72DQ38779963-33655553-F7A8-4D4A-8076-DC9B9EF26FAAQ39021867-8DC618BB-51FD-41D5-9717-AF5397E63466Q39574426-A624A7C1-2CE1-44A7-A167-489F08406483Q40028715-87B805D4-CAC3-48E1-9B46-37D4C58FDC83Q40461267-024D3130-37FC-40E6-BC15-92A48AF19883Q44337647-B7C485AB-9190-4986-A87F-4D71A4184888Q45377566-660BC802-837C-4DAF-8A1D-9600278001FDQ60170562-40C1A67C-A8DF-4A44-BDFC-BCFBE613B80EQ80757169-BCC4B7EB-2569-448B-BCBC-9342A9DBF1BEQ91819126-853CE41C-9BD0-4178-B9E0-3BB04E565BA3Q91979253-AD32B194-DE21-48E2-BDFC-2DF828A58F67Q95844682-81D8D8F7-5637-4FAC-B523-1FB5C2087A50
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alessandro Monaco
@ast
Alessandro Monaco
@en
Alessandro Monaco
@es
Alessandro Monaco
@nl
Alessandro Monaco
@sl
type
label
Alessandro Monaco
@ast
Alessandro Monaco
@en
Alessandro Monaco
@es
Alessandro Monaco
@nl
Alessandro Monaco
@sl
prefLabel
Alessandro Monaco
@ast
Alessandro Monaco
@en
Alessandro Monaco
@es
Alessandro Monaco
@nl
Alessandro Monaco
@sl
P106
P21
P31
P496
0000-0002-9941-7003